HUP0202537A2 - Vakcinakészítmény és eljárás annak alkalmazására - Google Patents

Vakcinakészítmény és eljárás annak alkalmazására

Info

Publication number
HUP0202537A2
HUP0202537A2 HU0202537A HUP0202537A HUP0202537A2 HU P0202537 A2 HUP0202537 A2 HU P0202537A2 HU 0202537 A HU0202537 A HU 0202537A HU P0202537 A HUP0202537 A HU P0202537A HU P0202537 A2 HUP0202537 A2 HU P0202537A2
Authority
HU
Hungary
Prior art keywords
subject
same
vaccine composition
vaccine
immunization
Prior art date
Application number
HU0202537A
Other languages
English (en)
Inventor
Norbert Frydman
Gilad Gallili
Original Assignee
Teva Pharmaceutical Industries, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharmaceutical Industries, Ltd. filed Critical Teva Pharmaceutical Industries, Ltd.
Publication of HUP0202537A2 publication Critical patent/HUP0202537A2/hu
Publication of HUP0202537A3 publication Critical patent/HUP0202537A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

A találmány tárgya stabil, tömörített, préselt vagy keménytablettázott vakcinakészítmény, amely legalább egy liofilizáltantigenikus komponenst valamint oldódást elősegítő anyagot tartalmaz.Szintén a találmány tárgyát képezi eljárás egy alany betegség elleniimmunizálásának gyorsításra, amely szerint a tömörített, préselt vagykemény, tablettázott vakcinakészítményt először feloldjuk egycsomagolásban oldószerrel vakcinaoldatot állítanak elő és azeredményül kapott vakcinaoldatot beadják akkora mennyiségben, amelyhatásos az immunizálásra. Ó
HU0202537A 1999-08-24 2000-08-21 A vaccine composition and method of using the same HUP0202537A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15051499P 1999-08-24 1999-08-24

Publications (2)

Publication Number Publication Date
HUP0202537A2 true HUP0202537A2 (hu) 2002-11-28
HUP0202537A3 HUP0202537A3 (en) 2004-05-28

Family

ID=22534899

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0202537A HUP0202537A3 (en) 1999-08-24 2000-08-21 A vaccine composition and method of using the same

Country Status (21)

Country Link
US (1) US6541001B1 (hu)
EP (1) EP1212045B1 (hu)
JP (1) JP5209160B2 (hu)
CN (1) CN100406004C (hu)
AU (1) AU779403B2 (hu)
BR (1) BRPI0014142B8 (hu)
CA (1) CA2382652A1 (hu)
CY (1) CY1118521T1 (hu)
DK (1) DK1212045T3 (hu)
ES (1) ES2605109T3 (hu)
HK (1) HK1047696A1 (hu)
HU (1) HUP0202537A3 (hu)
IL (2) IL148247A0 (hu)
LT (1) LT1212045T (hu)
MX (1) MXPA02001891A (hu)
PL (1) PL364983A1 (hu)
PT (1) PT1212045T (hu)
RU (1) RU2277905C2 (hu)
TR (1) TR200200477T2 (hu)
WO (1) WO2001013896A1 (hu)
ZA (1) ZA200201816B (hu)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6592869B2 (en) * 1999-08-24 2003-07-15 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same
US7923023B2 (en) * 2002-02-25 2011-04-12 Astech International LLC Method and composition for delivery of medicants to animals
CA2512735C (en) * 2003-01-07 2016-03-08 Yeda Research And Development Co. Ltd. Eye-drop vaccine containing copolymer 1 for therapeutic immunization
WO2004075875A1 (en) * 2003-02-28 2004-09-10 Alk-Abello A/S Dosage form having a saccharide matrix
US8012505B2 (en) 2003-02-28 2011-09-06 Alk-Abello A/S Dosage form having a saccharide matrix
US7858607B2 (en) * 2003-03-14 2010-12-28 Mamchur Stephen A System for use by compounding pharmacists to produce hormone replacement medicine customized for each consumer
US20050208083A1 (en) * 2003-06-04 2005-09-22 Nanobio Corporation Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof
US20050089502A1 (en) * 2003-08-21 2005-04-28 Todd Schansberg Effervescent delivery system
JP5183068B2 (ja) * 2003-12-22 2013-04-17 フィンレイ，ウォーレン，エイチ 大気噴出凍結乾燥法による粉末形成
US20050175630A1 (en) * 2003-12-23 2005-08-11 Eyal Raz Immunogenic compositions and methods of use thereof
JP2006143594A (ja) * 2004-11-16 2006-06-08 Shionogi & Co Ltd 注射錠
EP1973406B1 (en) 2005-12-28 2014-03-12 Advanced Bionutrition Corporation A delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form
EP1981547B1 (en) * 2005-12-28 2015-09-30 Alza Corporation Stable therapeutic formulations
DE102006054260A1 (de) * 2006-02-28 2007-09-27 Lohmann Animal Health Gmbh & Co. Kg Wasser stabilisierende Zusammensetzung, Verfahren zu deren Herstellung und deren Verwendung
JP4935761B2 (ja) * 2008-06-02 2012-05-23 株式会社微生物化学研究所 家禽大腸菌症ワクチン
NZ597053A (en) 2009-05-26 2014-02-28 Advanced Bionutrition Corp Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making
EP2529004B1 (en) 2010-01-28 2017-06-07 Advanced Bionutrition Corporation Dry glassy composition comprising a bioactive material
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
TW201233803A (en) 2010-12-02 2012-08-16 Oncolytics Biotech Inc Lyophilized viral formulations
JP6034798B2 (ja) 2010-12-02 2016-11-30 オンコリティクス バイオテク，インコーポレーテッド 液体ウイルス製剤
LT2741740T (lt) 2011-08-12 2017-08-10 Merial, Inc. Biologinių produktų, ypatingai vakcinų, vakuuminis konservavimas
NZ628912A (en) * 2012-03-23 2016-06-24 Advanced Bionutrition Corp Stabilizing composition for biological materials
TWI745278B (zh) 2014-10-10 2021-11-11 以色列商艾畢克生物實驗有限公司 發泡性降低之疫苗組合物
CN114145879A (zh) 2014-12-22 2022-03-08 美国乔治亚大学研究基金公司 用于禽类疫苗接种的系统及方法
WO2017019273A1 (en) 2015-07-29 2017-02-02 Advanced Bionutrition Corporation Stable dry probiotic compositions for special dietary uses

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB929377A (en) 1961-02-09 1963-06-19 Carl Peter Varnet Foot and mouth disease implantation preparations
US3317393A (en) 1964-06-08 1967-05-02 Robert M Chanock Immunization by selective infection of the intestinal tract with an encapsulated live virus
US3458621A (en) 1966-08-31 1969-07-29 American Home Prod Tablet dosage-form for the immunization of the intestinal tract with live virus preparations
US3603030A (en) 1969-08-29 1971-09-07 Remco Ind Inc Jumping toy
FR2082760A5 (en) 1970-03-26 1971-12-10 France Etat Aerosol immunisation appts - for freeze-dried vaccines
DD106660A1 (hu) 1972-04-10 1974-06-20
US3893280A (en) 1972-06-21 1975-07-08 Burns Biotec Lab Inc Transfer packaging for biologicals
DE2237783A1 (de) 1972-08-01 1974-02-14 Bayern Freistaat Impfstoffzubereitung zur oralen pocken-impfung
DD117250A1 (hu) 1974-11-20 1976-01-05
BE853923A (fr) 1977-04-25 1977-10-25 Rit Rech Ind Therapeut Nouveau vaccin vivant ameliore contre le pseudopeste aviaire et son procede de preparation
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4251509A (en) 1980-01-31 1981-02-17 Wisconsin Alumni Research Foundation Dry particulate vaccine for oral administration
US4458630A (en) 1982-06-22 1984-07-10 The United States Of America As Represented By The Secretary Of Agriculture Disease control in avian species by embryonal vaccination
HU188847B (en) * 1983-02-22 1986-05-28 Human Oltoanyagtermeloe Es Kutato Intezet,Hu Process for producing liophylized combined vaccines
JPS63264518A (ja) * 1987-04-21 1988-11-01 Wakamoto Pharmaceut Co Ltd 発泡性錠剤の製法
IE61575B1 (en) 1987-05-04 1994-11-16 Merck & Co Inc A stable lyophilized live herpes virus vaccine
US5710014A (en) 1988-02-11 1998-01-20 The United States Of America As Represented By The Department Of Health And Human Services Cloned cDNA for human procathepsin l.
US5472710A (en) 1988-04-16 1995-12-05 Schwarz Pharma Ag Pharmaceutical preparation to be administered orally with controlled release of active substance and method for its manufacture
IL89899A (en) 1988-05-16 1992-12-01 Reynolds Tobacco Co R Smoking article with improved means for delivering flavorants
US5350741A (en) 1988-07-30 1994-09-27 Kanji Takada Enteric formulations of physiologically active peptides and proteins
DE69030383T2 (de) * 1989-10-02 1997-10-23 Univ Arkansas Impfstoff-Konjugate zur Behandlung von Vogelkrankheiten
WO1991004757A1 (en) 1989-10-02 1991-04-18 Cima Labs, Inc. Effervescent dosage form and method of administering same
WO1991004750A1 (en) * 1989-10-02 1991-04-18 Embrex, Inc. Method of treatment
DD289201A5 (de) 1989-11-28 1991-04-25 Fi Fuer Lungenkrankheiten Und Tuberkulose,De Verfahren zur herstellung einer immunmodulierenden vakzine gegen viren
DD289200A5 (de) 1989-11-28 1991-04-25 Forsch Lungenkrankheiten Und T Verfahren zur herstellung einer kombinationsvakzine mit intensivierter wirkung
US5091188A (en) 1990-04-26 1992-02-25 Haynes Duncan H Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
FR2662942B1 (fr) * 1990-06-06 1992-09-18 Neway Tsehay Medicament immunostimulant a base de glycopeptidolipides polaires de mycobacterium chelonae.
US5178882A (en) 1990-06-22 1993-01-12 The Regents Of The University Of California Viral decoy vaccine
NZ286242A (en) 1991-03-26 1997-11-24 Csl Ltd Use of veterinary implant as a single dose vaccination system: rupturable polymer film coating around core of active agent and water soluble excipient
US5206219A (en) 1991-11-25 1993-04-27 Applied Analytical Industries, Inc. Oral compositions of proteinaceous medicaments
AU4660893A (en) * 1992-07-06 1994-01-31 President And Fellows Of Harvard College Deletion mutants as vaccines for cholera
WO1994017813A1 (en) 1993-02-08 1994-08-18 Paravax, Inc. Defective sindbis virus vectors that express toxoplasma gondii p30 antigens
US5780028A (en) * 1993-09-20 1998-07-14 Anadis Ltd. Method of obtaining immunoglobulins from colostrum and their use in pharmaceutical composition
US5595761A (en) 1994-01-27 1997-01-21 The Board Of Regents Of The University Of Oklahoma Particulate support matrix for making a rapidly dissolving tablet
US5576014A (en) 1994-01-31 1996-11-19 Yamanouchi Pharmaceutical Co., Ltd Intrabuccally dissolving compressed moldings and production process thereof
US5635210A (en) * 1994-02-03 1997-06-03 The Board Of Regents Of The University Of Oklahoma Method of making a rapidly dissolving tablet
IL120202A (en) * 1996-03-07 2001-03-19 Akzo Nobel Nv Container with freeze-dried vaccine components
US5912014A (en) 1996-03-15 1999-06-15 Unigene Laboratories, Inc. Oral salmon calcitonin pharmaceutical products
JP2000509036A (ja) * 1996-04-22 2000-07-18 ピーター・アール・ロスチャイルド 安定化された抗ｂ型肝炎ワクチンタブレット
HRP970493A2 (en) 1996-09-23 1998-08-31 Wienman E. Phlips Oral delayed immediate release medical formulation and method for preparing the same
AU4133397A (en) * 1996-10-28 1998-05-22 Pfizer Inc. Oral vaccines for young animals with an enteric coating
US6150340A (en) * 1997-02-07 2000-11-21 Smithkline Beecham Corporation RNA-dependent amidotransferase from Staphylococcus aureus
JPH1121122A (ja) * 1997-07-03 1999-01-26 Akou Kaisui Kk 水溶解性に優れた塩錠剤
DE19741114C2 (de) 1997-09-12 2002-10-24 Riemser Arzneimittel Ag Feuchtigkeitsstabile und magensaftresistente Arzneiform für Fische
CU22700A1 (es) 1997-09-29 2001-07-31 Ct Ingenieria Genetica Biotech Formulación farmacéutica anti-viral que contiene un péptido de la proteína factor anti-lps de limulus y su uso
GB9722682D0 (en) 1997-10-27 1997-12-24 Scherer Ltd R P Pharmaceutical products
GB9801870D0 (en) 1998-01-28 1998-03-25 Raby Limited Vaccine composition
JP2002537030A (ja) 1999-02-16 2002-11-05 プリスメディカル コーポレーション 一投与量放出装置

Also Published As

Publication number Publication date
BRPI0014142B8 (pt) 2021-05-25
TR200200477T2 (tr) 2002-06-21
BRPI0014142B1 (pt) 2016-09-27
HUP0202537A3 (en) 2004-05-28
HK1047696A1 (zh) 2003-03-07
ES2605109T3 (es) 2017-03-13
WO2001013896A1 (en) 2001-03-01
US6541001B1 (en) 2003-04-01
MXPA02001891A (es) 2003-07-21
CA2382652A1 (en) 2001-03-01
AU6793400A (en) 2001-03-19
IL148247A (en) 2014-01-30
CN1379663A (zh) 2002-11-13
JP5209160B2 (ja) 2013-06-12
RU2277905C2 (ru) 2006-06-20
PL364983A1 (en) 2004-12-27
EP1212045A1 (en) 2002-06-12
EP1212045B1 (en) 2016-08-17
CN100406004C (zh) 2008-07-30
EP1212045A4 (en) 2008-02-20
JP2003507414A (ja) 2003-02-25
LT1212045T (lt) 2016-12-12
PT1212045T (pt) 2016-11-22
AU779403B2 (en) 2005-01-20
BR0014142A (pt) 2002-07-02
CY1118521T1 (el) 2017-07-12
DK1212045T3 (en) 2016-11-28
IL148247A0 (en) 2002-09-12
ZA200201816B (en) 2003-05-28

Similar Documents

Publication Publication Date Title
HUP0202537A2 (hu) Vakcinakészítmény és eljárás annak alkalmazására
MY129263A (en) Vaccine composition
HUP0101619A2 (hu) Adjuvánskészítmények
HUP0303720A2 (hu) Egy immunstimuláns oligonukleotidot és egy tokolt tartalmazó adjuvánskészítmény
HUP0000839A2 (hu) Ciklosporint és egy anionos felületaktív szert tartalmazó szilárd gyógyszerkészítmények és eljárás ezek előállítására
ES2110377T1 (es) Formulacion galenica de fenofibrato y aplicacion de la misma.
DK1126828T3 (da) Oral indgivelse af adenosin-analoger
ATE276758T1 (de) Adjuvans-zusammensetzung, enthaltend saponin und ein immunstimulatorisches oligonukleotid
TR200100812T2 (tr) Akut ağrı tedavisi için fentanil kompozisyon.
BR9808933A (pt) Composição sob forma de microcápsulas ou de implantes, processo de preparação de uma substância hidrossolúvel, substância ativa, acetato de triptorelina, acetato de lanreotìdeo, ou acetato de octreotìdeo, e rna de filamento duplo
ATE270544T1 (de) Halbfeste arzneizubereitung enthaltend isotretinoin
NO20100302L (no) Sammensetninger som inneholder organiske forbindelser
DE69931930D1 (de) Verbindungen und zusammensetzungen zur verabreichung aktiven substanzen
BR9915988A (pt) Vacina para peptidase c5a estreptocócica
TR200001892T2 (tr) Monomer cinsi ensülin analogları ve bunların kullanımı.
ATE146360T1 (de) Gonadotropin enthaltende gefriergetrocknete troepfen
HUP0401606A2 (hu) West Nile vakcina
ATE224717T1 (de) Oral anzuwendende arzneizubereitungen enthaltend eine benzhydrylpiperazine und eine zyklodextrin
CY1109661T1 (el) 5-cnac ως παραγοντας για χορηγηση απο το στομα τμηματων παραθορμονης
HUP0301349A2 (hu) IL-11-tartalmú készítmények
CA2335551A1 (en) Thyroid hormone analogues and methods for their preparation
HUP0002683A2 (hu) Terápiás anyagok sejtekhez való eljuttatásának fokozására szolgáló készítmények és módszerek
WO2002067846A3 (en) A vaccine composition and method of using the same
DE68909100D1 (de) Physiologisch wirkende Substanzen, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen davon.
HUP0105070A2 (hu) Hepatitis B vírus fertőzések megelőzésére és kezelésére szolgáló készlet

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees